ACADIA Pharmaceuticals
ACAD
#4225
Rank
A$4.12 B
Marketcap
A$23.86
Share price
-22.28%
Change (1 day)
-30.15%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): A$0.17 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.13 Billion. In 2025 the company made an earning of A$0.20 Billion a decrease over its 2024 earnings that were of A$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.17 B-10.53%
2025 A$0.20 B-46.18%
2024 A$0.37 B-605.67%
2023 -A$73.81 Million-76.09%
2022 -A$0.31 Billion27.41%
2021 -A$0.25 Billion-40.38%
2020 -A$0.41 Billion19.88%
2019 -A$0.34 Billion-3.92%
2018 -A$0.36 Billion-15.04%
2017 -A$0.42 Billion6.33%
2016 -A$0.4 Billion64.55%
2015 -A$0.24 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$54.89 Million81.93%
2012 -A$30.17 Million-8.73%
2011 -A$33.05 Million-251.39%
2010 A$21.83 M-133.2%
2009 -A$65.76 Million-30.82%
2008 -A$95.05 Million6.43%
2007 -A$89.32 Million25.89%
2006 -A$70.95 Million36.99%
2005 -A$51.79 Million37.22%
2004 -A$37.74 Million19.96%
2003 -A$31.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.07 B 15,324.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.98 B 5,590.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$50.28 B 28,547.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.38 B 9,236.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion-252.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$55.87 Million-131.83%๐Ÿ‡บ๐Ÿ‡ธ USA